ArticleOncogene2015

Glioma-specific Domain IV EGFR cysteine mutations promote ligand-induced covalent receptor dimerization and display enhanced sensitivity to dacomitinib in vivo.

S A Greenall et al.PubMed ↗Publisher ↗

No numbers read from the abstract.